pj009
Peptideexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 28, 2023 (NCT06523101)
Timeline
Indications
Studied for
Mechanism of action
GLP2R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06512584 | Phase 3 | Sep 3, 2024 | Government of China, Huazhong University of Science and Technology |
| NCT06523101 | Phase 1 | Feb 28, 2023 | Government of China, Shanxi Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 2 | 2023 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Shanxi Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1